Tryp Therapeutics Inc.
TRYPF · OTC
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $2,064 | $345 | $1,256 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $48 | $29 | $23 |
| Inventory | $0 | $32 | $53 | $78 |
| Other Curr. Assets | $0 | $37 | $54 | $96 |
| Total Curr. Assets | $2 | $2,181 | $482 | $1,453 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $171 | $171 | $171 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | -$0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $171 | $171 | $171 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2 | $2,353 | $653 | $1,624 |
| Liabilities | – | – | – | – |
| Payables | $3 | $1,925 | $1,881 | $1,840 |
| Short-Term Debt | $16 | $5,013 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$0 | $31 | $90 | $0 |
| Total Curr. Liab. | $19 | $6,969 | $1,971 | $1,840 |
| LT Debt | $0 | $0 | $2,103 | $1,229 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $276 | $339 | $564 |
| Total NC Liab. | $0 | $276 | $2,442 | $1,794 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $19 | $7,245 | $4,413 | $3,633 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $40 | $13,497 | $13,497 | $13,497 |
| Retained Earnings | -$71 | -$22,600 | -$21,439 | -$19,749 |
| AOCI | $2 | $655 | $655 | $734 |
| Other Equity | -$59,964 | $3,555 | $3,527 | $3,509 |
| Total Equity | -$18 | -$4,893 | -$3,760 | -$2,009 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2 | $2,353 | $653 | $1,624 |
| Net Debt | $15 | $2,949 | $1,758 | -$26 |